| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |